Multicenter Study of the Hemorrhage Risk after Endoscopic Mucosal Resection Associated with Direct Oral Anticoagulants

Table 2

The comparison between cases with and without POH after endoscopic mucosal resection in patients with DOACs.

	DOAC users POH	DOAC users No POH	value
Lesion number	5	130
Morphology (% ()); Polypoid/nonpolypoid	80.0 (4)/20.0 (1)	86.2 (112)/13.8 (18)	0.69
Tumor size (mm), mean (range, min-max)	(4-25)	(3-30)	<0.001
Rate of (% ())	60.0 (3)	4.6 (6)	<0.001
Tumor location (% ()); Right-sided/left-sided/rectum	60.0/20.0/20.0; (3/1/1)	48.5/42.3/9.2; (63/55/12)	0.52
Histology (% ()); (SSAP/Ad/HGD/T1/others)	0/40.0/60.0/0/0; (0/2/3/0/0)	3.8/83.8/7.7/2.3/2.3; (5/109/10/3/3)	0.37
Coprescription of antiplatelet (% ())	0 (0)	14.6 (19)	0.35

DOAC: direct oral anticoagulant; POH: postoperative hemorrhage; min: minimum; max: maximum; right-sided: cecum to transverse colon; left-sided: descending colon to sigmoid colon; SSAP: sessile serrated adenoma and polyp; Ad: low-grade adenoma; HGD: high-grade dysplasia.